WithdrawnPhase 2NCT00696007

Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer

Studying Upper tract urothelial carcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Lahey Clinic
Principal Investigator
Christopher G. Tretter, M.D., M.D
Lahey Clinic, Inc.
Intervention
Gemcitabine and cisplatin(drug)
Eligibility
18 years · All sexes
Timeline
20082010

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00696007 on ClinicalTrials.gov

Other trials for Upper tract urothelial carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Upper tract urothelial carcinoma

← Back to all trials